IfPA’s Patient Access Policy Blog

Who Pays the Price for Health Plans’ Soaring Profits?

UnitedHealth Group announced higher than expected earnings this week, celebrating an 18 percent year-over-year increase to $185 billion in 2106 revenue.  But not everyone’s cheering.

Read More

FDA Settles on Random Suffix Approach for Naming Biologics & Biosimilars

The names of biologic and biosimilar medicines will include randomly generated four-letter suffixes, the Food and Drug Administration announced Thursday. The agency’s final guidance followed

Read More

Advocates & Physicians Speak Out on Potential Vaccine Panel

News on Tuesday that President-elect Donald Trump may form a federal panel on vaccine safety prompted outcry from physicians and advocates.  Word of the panel

Read More

For Affordable Care Act Patients, Cancer Treatment Access May Fall Short

About 83 percent of Americans say they could depend upon their health insurer if diagnosed with a serious illness like cancer, according to Aimed Alliance

Read More

New York Governor Signs Step Therapy Bill into Law

New York Governor Andrew Cuomo has signed into law a bill that protects patients from step therapy, marking a victory for advocates in the state. 

Read More

What Reduced Opioid Prescribing Means for Patients and Policy

New polling data from The Boston Globe reveals that U.S. physicians are prescribing fewer opioids. But how does the trend impact patients – and the

Read More

2016 in Review: Top Trends for Patient Access

  Hepatitis C patients keep waiting…and waiting…and waiting. Decreasing prices for treatment, the threat of legal action and input from the Centers for Medicare and

Read More

Hepatitis C and Opioid Abuse Epidemics Combine to Pose New Crisis

Two American public health epidemics are colliding – creating new headaches for policymakers and more heartache for communities across the country. As the opioid abuse

Read More

New Biosimilar Switching Paper Prioritizes Physician-Patient Relationship and Robust Pharmacovigilance

By Brian Kennedy, Executive Director, Global Alliance for Patient Access A new position paper from the European Crohn’s and Colitis Organisation has garnered attention from physicians and patient advocates

Read More

Webinar Offers Primer on Biosimilars Policy

If policymakers get it right, biosimilars could offer more safe and effective treatment options for patients in the coming years – potentially at lower costs.

Read More
Back to Top